Cardica to Announce Fiscal 2008 Third Quarter Financial Results on Tuesday, Apri... ( REDWOOD CITY Calif. April 22 /- C...)

Cardica to Announce Fiscal 2008 Third Quarter Financial Results on Tuesday, April 29, 2008

Date:4/22/2008

REDWOOD CITY, Calif., April 22 /PRNewswire-FirstCall/ -- Cardica, Inc. (Nasdaq: CRDC) today announced that it will release financial results for its fiscal third quarter ended March 31, 2008, on Tuesday, April 29, 2008, after the markets close, and the company's management will host a conference call at 4:30 p.m. Eastern Time to discuss the financial results and provide an update on the company's business.

Conference Call Details

To access the live conference call on April 29, 2008, at 4:30 p.m. Eastern Time via phone, please dial 866-700-6067 in the United States and Canada or 617-213-8834 internationally. The passcode is 73889016. Please dial in approximately 10 minutes prior to the start of the call. A telephone replay will be available beginning approximately one hour after the call through May 6, 2008, and may be accessed by dialing 888-286-8010 from the United States and Canada or 617-801-6888 internationally. The replay passcode is 87854369.

To access the live and subsequently archived webcast of the conference call, go to the Investor Relations section of Cardica's website at http://www.cardica.com. Please connect to the website at least 15 minutes prior to the call to allow for any necessary software downloads.

The webcast is also being distributed through the Thomson StreetEvents Network. Individual investors can listen to the call at http://www.earnings.com, Thomson's individual investor portal, powered by StreetEvents. Institutional investors can access the call via Thomson StreetEvents (http://www.streetevents.com), a password-protected event
'/>"/>

SOURCE Cardica, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2
Related medicine news :

1. Cardica Announces Proposed Public Offering of Common Stock
2. Cardica Announces Pricing of $34.7 Million Public Offering of Common Stock
3. Cardica Announces Live Webcast Demonstrating Breakthrough Device to Facilitate Beating Heart and Robotic Coronary Revascularization Surgery
4. Cardica Announces Exercise of Over-Allotment Option
5. Cardica to Announce Fiscal 2008 Second Quarter Financial Results on Thursday, January 24, 2008
6. Cardicas C-Port Anastomosis Systems for Coronary Artery Bypass Graft Procedures to be Used to Train Cardiothoracic Surgeons at Society of Thoracic Surgeons (STS) University
7. Cardicas C-Port Anastomosis Systems Facilitate Beating Heart Bypass Surgery in Study
8. HHS Announces $75 Million in Supplemental Funding to States for Pandemic Flu Preparedness
9. CRC Health Group Announces Acquisition of Bayside Marin Recovery Center, San Rafael
10. UHW Announces: Antelope Valley Hospital Caregivers and Board Vote to Ratify First Union Contract With SEIU UHW-West
11. HEI, Inc. Announces Sale of RFID Division Assets

Post Your Comments:

(Date:11/9/2009)...Nov. 9 At a time when the 250,000+...ingly concerned about finding affordable health in...on for 2010. ,, The Today,s Options® Prefe...e plan provides a cost-effective and comprehensive...pplement plan. People with Medicare can choose to...

(Date:11/9/2009)... The American Academy of...an 75,000 clinically practicing physician assistan... the U.S. House of Representatives for passing Sat...Affordable Health Care for America Act. ,, "We ...l ultimately lower the cost of health care and gre...

(Date:11/9/2009)...earch Hospital and the University of Florida Proto... provide proton therapy for St. Jude patients. The...inical study to evaluate the use of proton therapy... years old. , Under the clinical protocol, St....y at the UF Proton Therapy Institute in Jacksonvil...

(Date:11/9/2009)...9, 2009 Shire plc (LSE: SHP, NASDAQ: SHPGY), the ...announced the availability of INTUNIV (guanfacine)... United States for the treatment of Attention-Defi...adolescents ages 6 to 17. INTUNIV, a once-daily f...nscheduled alpha-2A receptor agonist approved for ...

(Date:11/9/2009)... 2009 The first human embryonic stem cell treatme...shown to restore limb function in rats with neck s...he clinical trial to include people with cervical ...istration gave Geron Corp. of Menlo Park, Calif., ...viduals with thoracic spinal cord injuries, which ...

Breaking Medicine News(10 mins):Health News:Maine Residents With Medicare Searching for Affordable and Innovative Insurance Have Competitive Medicare Advantage Option 2 Health News:American Academy of Physician Assistants Applauds U.S. House of Representatives for Passing Health Care Reform Bill 2 Health News:St. Jude and UF Proton Therapy Institute to begin proton therapy clinical trial 2 Health News:Once-daily INTUNIV (guanfacine) extended release tablets now available in US pharmacies 2 Health News:Once-daily INTUNIV (guanfacine) extended release tablets now available in US pharmacies 3 Health News:Once-daily INTUNIV (guanfacine) extended release tablets now available in US pharmacies 4 Health News:UCI embryonic stem cell therapy restores walking ability in rats with neck injuries 2

[0] Maine Residents With Medicare Searching for Affordable and Innovative Insurance Have Competitive Medicare Advantage Option [0] American Academy of Physician Assistants Applauds U.S. House of Representatives for Passing Health Care Reform Bill [0] St. Jude and UF Proton Therapy Institute to begin proton therapy clinical trial [0] Once-daily INTUNIV (guanfacine) extended release tablets now available in US pharmacies [0] UCI embryonic stem cell therapy restores walking ability in rats with neck injuries

... China, Nov. 7 /Xinhua-PRNewswire-FirstCall/ -- Ch...lletin Board: CPHI), which,develops, manufactures,...ceutical products in China, today announced financ...lion Revenue for nine months ended September 30, u...

... health plans evaluated based on quality of care, ...oup and The,National Committee for Quality Assuran... of America,s Best Health Plans on USNews.com. Lau... provides,comprehensive rankings and important con...

...Fraxel laser treatment highlighted in several podi...gic Surgery,s Annual Meeting, ORLANDO, Fla., Nov....ctional resurfacing and market leader of aesthetic...ed at the,American Society for Dermatologic Surger...

...e brand with mangosteen BioActiveX3 Complex(TM) fe...chnology in self-adjusting ...nutrition leader XanGo,LLC, today announced the of...ingredients from the mangosteen delivered through,...

.... 7 NutraCea (OTC Bulletin Board:,NTRZ), a world ...arch and,technology, today announced financial res...8., Net revenues for the 2008 third quarter incre...venues from the,Company,s NutraCea segment and $7....

..., Mich., Nov. 7 The,patient-centered medical home... coverage will be among the topics at the annual "...igan State Medical Society (MSMS),on Tuesday, Nov....of the emerging health care model that ensures coo...

China Pharma Holdings, Inc. Reports Third Quarter 2008 Financial Results and Corporate Updates U.S. News Media Group and NCQA Release 2008 Rankings for America's Best Health Plans Fraxel(R) Laser Systems Shown to Provide Superior Results Compared to 'Pseudo Fractional' Laser Technologies XanGo Introduces Glimpse(TM) Intuitive Skin Care NutraCea Announces Third Quarter 2008 Financial Results 'Best Minds, Best Practices' in Medicine Conference on Nov. 11

(Date:11/9/2009)...ov. 9 PAREXEL Internatio... biopharmaceutical services provider, today announ...lities for early phase clinical development throug... manufactures and distributes electrocardiogram (E...XEL is using Mortara Instrument,s Surveyor Telemet...

(Date:11/7/2009)...CH, Fla., Nov. 7 Most patients wit...oms that signal an oncoming HAE attack giving the ... decrease the morbidity associated with that attac... the 2009 American College of Allergy, Asthma &...tion of symptoms such as fatigue and nausea, which...

(Date:11/6/2009)...N, Mass., Nov. 6 DUSA Ph...ermatology company that is developing and marketin...ther products focused on patients with common skin...nd Chief Executive Officer, will present a corpora...ummit 2009 on Tuesday, November 10, 2009 at 10:00 ...

Breaking Medicine Technology:PAREXEL Enhances Early Phase Cardiac Safety Capabilities Through Alliance With Mortara Instrument 2 PAREXEL Enhances Early Phase Cardiac Safety Capabilities Through Alliance With Mortara Instrument 3 PAREXEL Enhances Early Phase Cardiac Safety Capabilities Through Alliance With Mortara Instrument 4 PAREXEL Enhances Early Phase Cardiac Safety Capabilities Through Alliance With Mortara Instrument 5 Prodromal Symptoms Warn of Hereditary Angioedema Attacks, Give Patients Time to Start Therapy and Decrease Morbidity 2 Prodromal Symptoms Warn of Hereditary Angioedema Attacks, Give Patients Time to Start Therapy and Decrease Morbidity 3 BBV Vietnam S E A Acquisition Corp Announces Signing of Letter of Intent for Business Combination with Migami Inc 53392 1 BBV Vietnam S E A Acquisition Corp Announces Signing of Letter of Intent for Business Combination with Migami Inc 53392 2 Excaliard Pharmaceuticals Appoints Jay Birnbaum Ph D to the Board of Directors 53389 1 Excaliard Pharmaceuticals Appoints Jay Birnbaum Ph D to the Board of Directors 53389 2 Blood Transfusions Not Linked to Long Term Problems 53386 1

[0] PAREXEL Enhances Early Phase Cardiac Safety Capabilities Through Alliance With Mortara Instrument [0] Prodromal Symptoms Warn of Hereditary Angioedema Attacks, Give Patients Time to Start Therapy and Decrease Morbidity [0] DUSA Pharmaceuticals to Present at the Merriman Curhan Ford Investor Summit 2009

...s Overall Psychological Toll Is Greater Than for A...Pa., May 17, 2007 /PRNewswire/ -- Nearly three out...cent) responding to a,new nationwide survey say no...urthermore, they describe UC as disruptive when it...cent), their sexual,relations (75 percent) and the...

...USALEM--(BUSINESS WIRE)--May 17, 2007 - BioLineRx ...nt company, announced today,that abstracts contain...linical trails of BL-1020, first in class GABA-enh...enia, have been,accepted for poster presentations ...will be presented at the following,conferences:, -...

Ulcerative Colitis (UC) Sufferers Find UC Quite Disruptive to Many,Aspects of Daily Life BioLineRx Presents Phase I Clinical Data of BL-1020 at Upcoming,Clinical Conferences

CA-125 Enzyme Immunoassay Test Kit

Immulite PAP

Mosaic

...s a neurosurgical OR that fully integrates all the...cessary to treat complicated neurosurgical cases. ... performed in a workflow optimized manner. Pre-tes...BrainSUITE iMRI guarantees rapid implementation in...

Medicine Products:

CA-125 Enzyme Immunoassay Test Kit Immulite PAP Mosaic BrainSUITE® iMRI

Cardica to Announce Fiscal 2008 Third Quarter Financial Results on Tuesday, Apri...( REDWOOD CITY Calif. April 22 /- C...),Health